How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs) pose a significant health risk due to their potential to cause life-threatening reactions, such as anaphylaxis. These conditions represent a critical area...